tirzepatide and fibromyalgia GLP-1 for Fibromyalgia: Research Update COULD “SKINNY SHOTS” CURE FIBROMYALGIA?

October 10th, 2025: New Study Suggests Ozempic May Interfere With Critical Cancer Imaging New research suggests that GLP-1 weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may interfere with PET-CT scan accuracy by altering how the bodys tissues absorb radioactive tracers

Schedule your consultation today to begin your personalized semaglutide program in Coral Gables

FOR PULMONARY ASPIRATION SOURCE: DailyMed

In this case, this patient is now left with 30 to 35 percent kidney function

This led to the development of higher-dose versions of GLP-1 drugs specifically for obesity: Saxenda was approved for weight loss in 2014 and then Wegovy was approved in 2021, demonstrating even more dramatic weight loss results

How does tirzepatide compare to other GLP-1 medications in terms of safety